Stryker stock faces analyst cuts as Stifel lowers target
Published on 09/30/2026 at 11:40 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS
Stryker stock was trading at EUR 246.00 at Lang & Schwarz on September 30, 2026, up 0.18 percent versus the Xetra close of EUR 245.55. The latest analyst revision puts revenue execution and orthopedic demand at the center of the medical technology companys near-term valuation.
Stifel lowers its target
According to Investing.com on September 29, 2026, Stifel cut its Stryker price target to USD 330.00 from USD 360.00 while keeping a Buy rating. The firm reduced its 2026 organic revenue growth estimate to 8.30 percent from 8.60 percent, placing it at the bottom of Strykers 8.30 percent to 9.30 percent guidance range.
Stifels revised model also puts adjusted 2026 EPS at USD 14.96, close to the lower end of Strykers USD 14.95 to USD 15.10 guidance. The analyst cited a more difficult second half and orthopedic headwinds, while identifying delayed elective joint procedures and backlog conversion as potential upside factors.
Second quarter delivered a beat
Strykers second-quarter 2026 results provide a stronger operating reference point. MarketBeat reported that EPS reached USD 3.69 versus USD 3.49 consensus, a USD 0.20 beat, while revenue rose 9.40 percent year over year to USD 6.59 billion versus USD 6.58 billion expected.
The company also maintained fiscal 2026 EPS guidance of USD 14.95 to USD 15.10. That combination gives investors a clear split-screen: quarterly earnings exceeded expectations, while the latest target cut reflects concerns about the pace and composition of future growth.
Stock valuation stays under pressure
Stryker had a market capitalization of USD 106.9 billion as of September 29, 2026. Its 52-week range was USD 267.00 to USD 392.55, leaving the latest US listing quote of USD 278.86 near the lower end of that span.
For the next checkpoint, TradingView identifies October 29, 2026, as Strykers next earnings date. The report will test whether the company can convert its USD 6.59 billion quarterly revenue base into the growth rate embedded in its full-year outlook.
Stryker stock holds near EUR 246
Stryker was trading at EUR 246.00 at Lang & Schwarz on September 30, 2026, at 11:33 a.m. CEST. The price was up 0.18 percent versus the Xetra close of EUR 245.55 on September 29, 2026.
Stryker stock facts
- Company: Stryker Corporation
- ISIN: US8636671013
- Ticker: SYK
- Primary exchange: NYSE
- Price Lang & Schwarz (as of September 30, 2026, 11:33 a.m. CEST): EUR 246.00
- Change versus Xetra close: plus 0.18 percent
- Xetra close (September 29, 2026): EUR 245.55
- Market capitalization: USD 106.9 billion (as of September 29, 2026)
- 52-week range: USD 267.00-392.55 (as of September 29, 2026)
- Sector / Industry: Healthcare / Medical Devices
- Next earnings date: October 29, 2026
